Serina Therapeutics (SER) Total Debt (2017 - 2025)

Serina Therapeutics has disclosed Total Debt across 9 years of filings, most recently posting $2.9 million for Q3 2025.

• In Q3 2025, Total Debt fell 74.11% year-over-year to $2.9 million; the TTM figure through Sep 2025 stood at $2.9 million (down 74.11% YoY), while the FY2022 annual figure was $18.3 million, up 37.62% from the prior year.
• Total Debt came in at $2.9 million for Q3 2025 at Serina Therapeutics, down from $11.2 million in the prior quarter.
• In the past five years, Total Debt ranged from a high of $33.0 million in Q2 2023 to a low of $2.2 million in Q3 2023.
• Average Total Debt over 5 years is $13.4 million, with a median of $11.2 million recorded in 2024.
• Year-over-year, Total Debt tumbled 85.87% in 2023 and surged 402.7% in 2024.
• Over 5 years, Total Debt stood at $13.3 million in 2021, then surged by 37.62% to $18.3 million in 2022, then sank by 87.85% to $2.2 million in 2023, then surged by 402.7% to $11.2 million in 2024, then sank by 74.11% to $2.9 million in 2025.
• Per Business Quant data, the three most recent Total Debt figures were $2.9 million in Q3 2025, $11.2 million in Q3 2024, and $11.1 million in Q2 2024.